Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone prophylaxis to reduce cerebral inflammation and cognitive dysfunction after cardiac surgery
2012-004232-37Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in post-operative cognitive decline (POCD), encephalitis, sponsored by Sahlgrenska University Hospital. Started Oct 2012; status: completed.
02
Drugs
methylprednisolone
03
Conditions
post-operative cognitive decline (POCD)encephalitis
Beyond the preview
Go deeper on 2012-004232-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004232-37.